UniProt/SwissProt ID: | EF1B_HUMAN |
Description: | eukaryotic translation elongation factor 1 beta 2 [Source:HGNC Symbol;Acc:3208] |
Location: | chr2 q33.3 |
Node attribute: | substrate |
Phosphorylation site |
Position | PhosphoPeptide | Catalytic kinase | Source |
---|---|---|---|
S8 | FGDLKsPAGLQ | PhosphoSitePlus; HPRD; SysPTM | |
S90 | EDTTGsGATDS | PhosphoSitePlus; HPRD | |
Y18 | QVLNDyLADKS | HPRD | |
T87 | ADVEDtTGSGA | PhosphoSitePlus; HPRD; phosphoELM | |
Y182 | LVPVGyGIKKL | EF1_GNE | PhosphoSitePlus |
Y213 | TAFEDyVQSMD | EF1_GNE | PhosphoSitePlus |
T88 | DVEDTtGSGAT | PhosphoSitePlus; HPRD | |
S95 | SGATDsKDDDD | PhosphoSitePlus; HPRD; phosphoELM; RegPhos; SysPTM | |
S106 | IDLFGsDDEEE | CK2a1-rs | RegPhos; SysPTM |
S112 | DDEEEsEEAKR | CK2a1-rs | RegPhos; SysPTM |
S112 | DDEEEsEEAKR | PhosphoSitePlus; HPRD; SysPTM | |
S106 | IDLFGsDDEEE | CK2a1 | RegPhos; SysPTM |
S106 | IDLFGsDDEEE | CK2a2 | RegPhos; SysPTM |
Y79 | KALGKyGPADV | PhosphoSitePlus; HPRD | |
S106 | IDLFGsDDEEE | CSNK2A2 | HPRD; SysPTM |
S128 | LAQYEsKKAKK | PhosphoSitePlus; HPRD; phosphoELM; RegPhos; SysPTM | |
S106 | IDLFGsDDEEE | CSNK2A1 | HPRD; SysPTM |
S112 | DDEEEsEEAKR | CK2a2 | RegPhos; SysPTM |
S112 | DDEEEsEEAKR | CK2a1 | RegPhos; SysPTM |
Y126 | ERLAQyESKKA | PhosphoSitePlus; HPRD; phosphoELM; RegPhos; SysPTM | |
S106 | IDLFGsDDEEE | PhosphoSitePlus; HPRD; phosphoELM; RegPhos; SysPTM | |
S112 | DDEEEsEEAKR | CSNK2A2 | HPRD; SysPTM |
S112 | DDEEEsEEAKR | CSNK2A1 | HPRD; SysPTM |
S141 | LVAKSsILLDV | HPRD; phosphoELM; RegPhos | |
S141 | LVAKSsILLDV | EF1_GNE | PhosphoSitePlus |
T93 | TGSGAtDSKDD | PhosphoSitePlus; HPRD; phosphoELM; RegPhos; SysPTM | |
Dephosphorylation site |
EF1B_HUMAN do not have dephosphorylation site. |
Mutation site |
Ensembl ID | Variation | Source | Cancer name | Pubmed |
---|---|---|---|---|
ENSP00000376055 | *226Y | COSMIC | Ovarian Cancer | 21720365 |
ENSP00000376056 | *226Y | COSMIC | Ovarian Cancer | 21720365 |
ENSP00000236957 | *226Y | COSMIC | Ovarian Cancer | 21720365 |
Differential expressed protein |
Ensembl ID | Cancer name | Design | Sample | Change | Ratio | Pubmed |
---|---|---|---|---|---|---|
ENSP00000376055 | Leukemia | Normal vs. Cancer | cell line | Down | 0.23 | 17022645 |
ENSP00000376055 | Leukemia | Normal vs. Cancer | cell line | Down | 0.36 | 17022645 |
ENSP00000376055 | Breast Cancer | Normal vs. Cancer | tissue | Up | 17127214 | |
ENSP00000376055 | Breast Cancer | Metastasis | cell line | Down | 0.77 | 18582095 |
ENSP00000376055 | Breast Cancer | Normal vs. Cancer | tissue | Up | 4.4 | 20005186 |
ENSP00000376055 | Breast Cancer | Normal vs. Cancer | tissue | Up | 20560667 | |
ENSP00000376055 | Oral Cancer | Normal vs. Cancer | tissue | Up | 2.4 | 19691830 |
ENSP00000376055 | acute myeloid leukemia | Treatment (none vs. NSC606985 treatment) | cell line | Down | 0.01 | 17655343 |
ENSP00000376055 | acute myeloid leukemia | Treatment (none vs. NSC606985 treatment) | cell line | Down | 0.11 | 17655343 |
ENSP00000376055 | acute myeloid leukemia | Treatment (none vs. NSC606985 treatment) | cell line | Down | 0.37 | 17655343 |
ENSP00000376055 | acute myeloid leukemia | Treatment (none vs. NSC606985 treatment) | cell line | Down | 0.14 | 17655343 |
ENSP00000376055 | acute myeloid leukemia | Treatment (none vs. NSC606985 treatment) | cell line | Down | 0.17 | 17655343 |
ENSP00000376055 | acute myeloid leukemia | Treatment (none vs. NSC606985 treatment) | cell line | Down | 0.31 | 17655343 |
ENSP00000376055 | acute myeloid leukemia | Treatment (none vs. NSC606985 treatment) | cell line | Down | 0.39 | 17655343 |
Hyperphosphorylation site |
EF1B_HUMAN do not have hyperphosphorylation site. |
Direct Interaction Pair |
Source | Target | Relationship | Resource |
---|---|---|---|
CSK22_HUMAN | EF1B_HUMAN | kinase -> substrate | HPRD |
CSK21_HUMAN | EF1B_HUMAN | kinase -> substrate | HPRD |
ZAGL2_HUMAN | EF1B_HUMAN | kinase -> substrate | RegPhos |
Function Annotation |
KEGG Pathway |
EF1B_HUMAN is not in KEGG pathway. |
Gene Ontology |
GO ID | GO_Term | Evidence | Ontology |
---|---|---|---|
GO:0010467 | gene expression | TAS | biological_process |
GO:0005515 | protein binding | IPI | molecular_function |
GO:0005829 | cytosol | TAS | cellular_component |
GO:0006414 | translational elongation | NAS | biological_process |
GO:0006412 | translation | TAS | biological_process |
GO:0044267 | cellular protein metabolic process | TAS | biological_process |
GO:0005853 | eukaryotic translation elongation factor 1 complex | IEA | cellular_component |
GO:0003746 | translation elongation factor activity | IEA | molecular_function |